Prevention of diabetes in NOD mice by a mutated I-Ab transgene.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Diabetes

• Publication date

  1998-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2337/DIABETES.47.10.1570PMID 9753294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High copy number I-Ab transgenes induce production of IgE through an interluekin 4-dependent mechanism.

  1996cited by this paper
• Insulin-dependent diabetes mellitus.

  1996cited by this paper
• Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

  1995cited by this paper
• A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity.

  1994cited by this paper
• Immunoregulatory and Cytokine Imbalances in the Pathogenesis of IDDM: Therapeutic Intervention by Immunostimulation?

  1994cited by this paper
• An Abd transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells.

  1993cited by this paper
• Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes

  1993cited by this paper
• In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen

  1993cited by this paper
• Split tolerance of Thl and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus

  1993cited by this paper
• Failure of a protective major histocompatibility complex class II molecule to delete autoreactive T cells in autoimmune diabetes.

  1993cited by this paper
• Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen.

  1993cited by this paper
• Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice

  1993cited by this paper
• The effect of bone marrow and thymus chimerism between non‐obese diabetic (NOD) and NOD‐E transgenic mice, on the expression and prevention of diabetes

  1993cited by this paper
• Adoptive Transfer of Diabetes Into Immunodeficient NOD-scid/scid Mice: Relative Contributions of CD4+ and CD8+ T-Cells From Diabetic Versus Prediabetic NOD.NON-Thy-1a Donors

  1993cited by this paper
• Peripheral tolerance to an islet cell‐specific hemagglutinin transgene affects both CD4+ and CD8+ T cells

  1992cited by this paper
• Strategies of Anti‐Cytokine Monoclonal Antibody Development: Immunoassay of IL‐10 and IL‐5 in Clinical Samples

  1992cited by this paper
• Peripherin: an islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products.

  1992cited by this paper
• Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain

  1992cited by this paper
• Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium.

  1991cited by this paper
• Subsets of CD4+ T Cells and their Roles in the Induction and Prevention of Autoimmunity

  1991cited by this paper
• Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes.

  1991cited by this paper
• Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen.

  1991cited by this paper
• Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase

  1990cited by this paper
• Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice

  1990cited by this paper
• MHC-linked protection from diabetes dissociated from clonal deletion of T cells.

  1990cited by this paper
• Immune deficiency due to high copy numbers of an Ak beta transgene.

  1990cited by this paper
• Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein.

  1990cited by this paper
• Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages

  1990cited by this paper
• Prevention of diabetes in non-obese diabetic I-Ak transgenic mice

  1990cited by this paper
• IL-4 directs the development of Th2-like helper effectors.

  1990cited by this paper
• Genetic control of autoimmunity in type 1 diabetes.

  1990cited by this paper
• T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins

  1990cited by this paper
• Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain.

  1990cited by this paper
• Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice.

  1989cited by this paper
• Syngeneic t cell transfer of diabetes into nod newborn mice: in situ studies of the autoimmune steps leading to insulin‐producing cell destruction

  1989cited by this paper
• Neonatal injection of CD3 antibody into nonobese diabetic mice reduces the incidence of insulitis and diabetes.

  1989cited by this paper
• The Role of Helper T Cell Products in Mouse B Cell Differentiation and Isotype Regulation

  1988cited by this paper
• Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes.

  1988cited by this paper
• Administration of Silica Particles or Anti-Lyt2 Antibody Prevents β-Cell Destruction in NOD Mice Given Cyclophosphamide

  1988cited by this paper
• Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes.

  1988cited by this paper
• Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice.

  1988cited by this paper
• Prevention of autoimmune insulitis by expression of I–E molecules in NOD mice

  1987cited by this paper
• The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique.

  1987cited by this paper
• Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice.

  1987cited by this paper
• The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex.

  1986cited by this paper
• Insulin antibodies in insulin-dependent diabetics before insulin treatment.

  1983cited by this paper
• The role of H-2 linked genes in helper T-cell function. IV. Importance of T-cell genotype and host environment in I-region and Ir gene expression

  1978cited by this paper

• Decoding autoimmunity: HLA-DQβ and type 1 diabetes.

  2025cites this paper
• I-A^g7 β56/57 polymorphisms regulate non-cognate negative selection to CD4^+ T cell orchestrators of type 1 diabetes

  2023cites this paper
• Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes

  2022cites this paper
• Preventing type 1 diabetes in late-stage pre-diabetic NOD mice with insulin: A central role for alum as adjuvant

  2022cites this paper
• HLA-DQβ57, anti-insulin T cells and insulin mimicry in autoimmune diabetes

  2022cites this paper
• Pleiotropic consequences of metabolic stress for the major histocompatibility complex class II molecule antigen processing and presentation machinery.

  2021cites this paper
• Blood leukocytes recapitulate diabetogenic peptide–MHC-II complexes displayed in the pancreatic islets

  2021cites this paper
• The MHCII peptidome of the pancreatic islet identifies key features of autoimmune peptides

  2020cites this paper
• The Immunoreactive Platform of the Pancreatic Islets Influences the Development of Autoreactivity

  2019cites this paper
• Position β57 of I-Ag7 controls early anti-insulin responses in NOD mice, linking an MHC susceptibility allele to type 1 diabetes onset

  2019cites this paper
• The Role of NOD Mice in Type 1 Diabetes Research: Lessons from the Past and Recommendations for the Future

  2018cites this paper
• Animal models of chronic inflammatory demyelinating polyneuropathy

  2018cites this paper
• Antigen presentation in the autoimmune diabetes of the NOD mouse.

  2014cites this paper
• and Determined by the Amino Acid Changes the Diabetogenic I-Ag7 Molecule Are Unique In APCs, the Autologous Peptides Selected by

  2013cites this paper
• Dendritic Cell–Dependent In Vivo Generation of Autoregulatory T Cells by Antidiabetogenic MHC Class II

  2013cites this paper
• The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-γ locus.

  2013cites this paper
• Development of Autoimmune Diabetes in Receptors Participate in the γ Activating Fc

  2013cites this paper
• MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity

  2013cites this paper
• Animal Models for Type 1 Diabetes

  2012cites this paper
• Gene and Cell Therapies for Diabetes Mellitus

  2012cites this paper
• Genetics of type 1 diabetes.

  2012cites this paper
• Comparative genetics: synergizing human and NOD mouse studies for identifying genetic causation of type 1 diabetes.

  2012cites this paper
• TRP Channels in Drug Discovery

  2012cites this paper
• Type 1 Diabetes Mellitus

  2011cites this paper
• The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity.

  2010cites this paper
• that modulates TCR affinity

  2010cites this paper
• PD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD mice

  2008influential citation
• Dysrulation of T cell peripheral tolerance in type 1 diabetes.

  2008cites this paper
• Gene therapy in type 1 diabetes.

  2008cites this paper
• Activating Fcγ Receptors Participate in the Development of Autoimmune Diabetes in NOD Mice1

  2007cites this paper
• HLA and Autoimmunity

  2006cites this paper
• CHAPTER 75 – Prevention of Autoimmune Disease: Type 1 Diabetes as a Paradigm

  2006cites this paper
• HLA and Autoimmunity: Structural Basis of Immune Recognition

  2006cites this paper
• The murine diabetogenic class II histocompatibility molecule I-Ag7: structural and functional properties and specificity of peptide selection.

  2005cites this paper
• NOD B-cells are insufficient to incite T-cell-mediated anti-islet autoimmunity.

  2005cites this paper
• Prevention of type 1 diabetes by gene therapy.

  2004cites this paper
• MHC Class II Molecules Play a Role in the Selection of Autoreactive Class I-Restricted CD8 T Cells That Are Essential Contributors to Type 1 Diabetes Development in Nonobese Diabetic Mice1

  2004cites this paper
• Invariant Chain Peptide Precursors /Class II-Associated g7 Generated from I-A Nonobese Diabetic Mice with Tetramers Ex Vivo Analysis of Thymic CD4 T Cells in

  2003cites this paper
• Severe anaphylactic reactions to glutamic acid decarboxylase (GAD) self peptides in NOD mice that spontaneously develop autoimmune type 1 diabetes mellitus

  2003cites this paper
• Anti-4-1BB-based immunotherapy for autoimmune diabetes: lessons from a transgenic non-obese diabetic (NOD) model.

  2003cites this paper
• Immunoregulation by cytokines in autoimmune diabetes.

  2003cites this paper
• Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competition

  2003cites this paper
• Diabetic Mice to Type 1 Diabetes Development in Nonobese CD 8 T Cells That Are Essential Contributors Selection of Autoreactive Class I-Restricted MHC Class II Molecules Play a Role in the DiLorenzo

  2003cites this paper
• Gene therapy technology applied to disorders of glucose metabolism: promise, achievements, and prospects.

  2003cites this paper
• Ex Vivo Analysis of Thymic CD4 T Cells in Nonobese Diabetic Mice with Tetramers Generated from I-Ag7/Class II-Associated Invariant Chain Peptide Precursors 1

  2003cites this paper
• MHC Class II Molecules Play a Role in the Selection of Autoreactive Class I-Restricted CD8 T Cells That Are Essential Contributors to Type 1 Diabetes Development in Nonobese Diabetic Mice

  2003cites this paper
• Therapeutic strategies for Type 1 and Type 2 diabetes mellitus.

  2002cites this paper
• NKT cell defects in NOD mice suggest therapeutic opportunities.

  2002cites this paper
• Cytokines and Resistance to Organ Specific Autoimmune Disease

  2002cites this paper
• In APCs, the Autologous Peptides Selected by the Diabetogenic I-Ag7 Molecule Are Unique and Determined by the Amino Acid Changes in the P9 Pocket1

  2002cites this paper
• Gene and cell therapies for diabetes mellitus: strategies and clinical potential.

  2002cites this paper
• in the P9 Pocket and Determined by the Amino Acid Changes Molecule Are Unique g7 the Diabetogenic I-A In APCs, the Autologous Peptides Selected by

  2002cites this paper
• Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases

  2002influential citation
• IL-12 Administration Reveals Diabetogenic T Cells in Genetically Resistant I-Eα-Transgenic Nonobese Diabetic Mice: Resistance to Autoimmune Diabetes Is Associated with Binding of Eα-Derived Peptides to the I-Ag7 Molecule1

  2001cites this paper
• Inhibition of Autoimmune Diabetes in Nonobese Diabetic Mice by Transgenic Restoration of H2-E MHC Class II Expression: Additive, But Unequal, Involvement of Multiple APC Subtypes1

  2001cites this paper
• A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins.

  2001cites this paper
• Approaches to Type 1 Diabetes Prevention by Intervention in Cytokine Immunoregulatory Circuits

  2001cites this paper
• Prevention of Diabetes in the NOD Mouse by Intra-muscular Injection of Recombinant Adeno-associated Virus Containing the Preproinsulin II Gene

  2001cites this paper
• Involvement of Multiple APC Subtypes Expression : Additive , But Unequal , Restoration of H 2E MHC Class II Nonobese Diabetic Mice by Transgenic Inhibition of Autoimmune Diabetes in

  2001cites this paper
• Gene Therapy for Autoimmune Disease and Transplantation

  2001cites this paper
• Understanding the interaction of genetics and cellular responses in nonobese diabetic mice.

  2001cites this paper
• Genetics of type 1 diabetes.

  2001cites this paper
• The role of MHC class II molecules in the pathogenesis and prevention of Type I diabetes.

  2001cites this paper
• Immunotherapy of immune-mediated diabetes

  2000cites this paper
• Gene therapy for type I diabetes mellitus

  2000cites this paper
• Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice.

  2000cites this paper
• A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.

  1999cites this paper
• Targeting autoimmune diabetes with gene therapy.

  1999cites this paper
• The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire.

  1999cites this paper
• The aetiology of Type 1 diabetes

  1999cites this paper
• Autoimmunity. What is the turning point?

  1999cites this paper
• The aetiology of Type I diabetes.

  1999cites this paper
• Autoimmune Diabetes-Transgenic Nonobese Diabetic Mice from α Class II Molecule That Protects E , the MHCg 7 A Peptide Binding Motif for I-E

  1999cites this paper
• From genome to aetiology in a multifactorial disease, type 1 diabetes

  1999cites this paper
• Position  57 of I-A g7 controls early anti-insulin responses in NOD mice, linking an MHC susceptibility allele to type 1 diabetes onset

  year unknowncites this paper